Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-World Effectiveness of Upadacitinib in Patients Joining Subgroups Either With Oligo- or Poly-ArtIcular Psoriatic Arthritis on Minimal Disease Activity

NCT04758117 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT04758117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04758117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-World Effectiveness of Upadacitinib in Patients Joining Subgroups Either With Oligo- or Poly-ArtIcular Psoriatic Arthritis on Minimal Disease Activity
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
February 4, 2021
Completion date
July 26, 2023
Enrollment
394 (actual)
Sites
93

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis